Several times daily
Regulatory updates
FDA, EMA, MHRA and Health Canada
Official announcements and public regulator records.
Data status and methodology
PharmaSignal brings public pharmaceutical records together without hiding where they came from. Source links are included where retained, and the platform separately evaluates freshness as datasets load.
Freshness monitoring is active.
17 dataset checks are defined. The dashboard shows DATA CURRENT, DATA AGING or DATA DELAY based on the records used in that session.
17 dataset checks are defined. The dashboard shows DATA CURRENT, DATA AGING or DATA DELAY based on the records used in that session.
Sources and expected cadence
Catalog refreshes as source records change
Drug approvals
FDA Drugs@FDA and EMA medicines register
Application, sponsor and regulatory-status links.
Weekly
Clinical trials
ClinicalTrials.gov
Active trial status, phase, enrollment, sponsor and dates.
Periodic source refresh
Patents and biologics
FDA Orange Book and Purple Book
Listed patent, exclusivity, reference-product and biosimilar records.
On demand
Chemical identity
PubChem
Identity, computed properties and structure depictions for exact compound matches.
Periodic
Company and market context
Public company sources, Yahoo Finance and Polygon.io
Company profiles, financial fundamentals and market context where available.
How to read the freshness signal
- DATA CURRENT means every loaded dataset with a known timestamp is inside its expected freshness window.
- DATA AGING means at least one loaded dataset is approaching that window.
- DATA DELAY means at least one loaded dataset is older than expected. Records remain visible so users can verify them at the source.
The signal covers datasets loaded during the current session. It is not a guarantee that a source authority has published every real-world event, and it does not independently validate the substance of a source record.
Research guidance and coverage
Research & Interpretation Guide · Coverage definitions and dated counts · Editorial, AI & Corrections Policy
Matching and interpretation
- Company, drug, trial and patent connections use identifiers, catalog relationships, normalized aliases, and in some views partial name matching. See the Research Guide for their distinct limits.
- Orange Book listings do not establish patent scope, enforceability, ownership, infringement or the actual date of market entry.
- Purple Book entries describe biologic licensing and biosimilar or interchangeability records. Patent-list flags do not provide a complete patent inventory.
- PubChem properties are shown only for exact chemical-identity matches. Computed properties and heuristic classifications are labeled.
- Financial and commercial-cliff figures are context, not investment advice.
Source attribution and reuse
Regulatory material is attributed to FDA, the European Medicines Agency (© EMA 1995–2026), MHRA, and Health Canada. ClinicalTrials.gov and PubChem information is sourced from the U.S. National Library of Medicine. PharmaSignal selects, formats, links, and summarizes records; its presentation is not an official regulator publication or endorsement.
Contains public sector information licensed under the Open Government Licence v3.0, where applicable to the linked UK material. Source-specific notices and third-party exclusions still apply. See the FDA website policies, EMA legal notice, Canada.ca terms, and NCBI policies. Third-party company, reference, and market data may have separate permissions; public availability is not a general redistribution license.